Andrew J. Leidner - Concepedia

Author

Andrew J. Leidner

Centers for Disease Control and Prevention ORCID

Also Known As

Andrew J Leidner, Andrew J. Leidner, Andrew Leidner, Anwaar ul Haq, Leidner, Andrew J.

Publications

2.5K

Citations

H-Index

Concepts

All Affiliations

Centers for Disease Control and Prevention National Center for Immunization and Respiratory Diseases University of Michigan Berry (United States)Texas A&M University

About

Andrew J. Leidner is an author at Centers for Disease Control and Prevention specializing in medicine, health economics, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	10	10	309
2	Public Health	8	8	215
3	Health Sciences	2	2	32
4	Business	1	1	12
5	Engineering	1	1	12

Andrew J. Leidner

Publications

2.2K

Citations

H-Index

Page 1

	Year	Citations
Use of 15-Valent Pneumococcal Conjugate Vaccine and 20-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Miwako Kobayashi, Jennifer L. Farrar, Ryan Gierke, MMWR Morbidity and Mortality Weekly Report	2022	326
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Updated Recommendations of the Advisory Committee on Immunization Practices Almea Matanock, Grace Lee, Ryan Gierke, MMWR Morbidity and Mortality Weekly Report	2019	324
Use of Recombinant Zoster Vaccine in Immunocompromised Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Tara C. Anderson, Nina B. Masters, Angela Guo, MMWR Morbidity and Mortality Weekly Report	2022	211
Association Between Social Vulnerability and a County’s Risk for Becoming a COVID-19 Hotspot — United States, June 1–July 25, 2020 Sharoda Dasgupta, Virginia B. Bowen, Andrew J. Leidner, MMWR Morbidity and Mortality Weekly Report	2020	209
Pneumococcal Vaccine for Adults Aged ≥19 Years: Recommendations of the Advisory Committee on Immunization Practices, United States, 2023 Miwako Kobayashi, Tamara Pilishvili, Jennifer L. Farrar, MMWR Recommendations and Reports	2023	144
Opening of Large Institutions of Higher Education and County-Level COVID-19 Incidence — United States, July 6–September 17, 2020 Andrew J. Leidner, Vaughn Barry, Virginia B. Bowen, MMWR Morbidity and Mortality Weekly Report	2021	130
Cost‐effectiveness of hepatitis C treatment for patients in early stages of liver disease Andrew J. Leidner, Harrell W. Chesson, Fujie Xu, Hepatology	2015	113
Use of 21-Valent Pneumococcal Conjugate Vaccine Among U.S. Adults: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Miwako Kobayashi, Andrew J. Leidner, Ryan Gierke, MMWR Morbidity and Mortality Weekly Report ImmunodeficienciesImmunologyAdvisory CommitteeVaccine HesitancyPreventive Medicine	2024	88
Use of 15-Valent Pneumococcal Conjugate Vaccine Among U.S. Children: Updated Recommendations of the Advisory Committee on Immunization Practices — United States, 2022 Miwako Kobayashi, Jennifer L. Farrar, Ryan Gierke, MMWR Morbidity and Mortality Weekly Report	2022	84
Expanded Recommendations for Use of Pneumococcal Conjugate Vaccines Among Adults Aged ≥50 Years: Recommendations of the Advisory Committee on Immunization Practices — United States, 2024 Miwako Kobayashi, Andrew J. Leidner, Ryan Gierke, MMWR Morbidity and Mortality Weekly Report	2025	84

Page 1